BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 21, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 20, 2006
View Archived Issues
Shire makes progress in third quarter
Read More
Newly identified H5N1 influenza virus variant spreads
Read More
Phase I study reveals safety concerns with XL-999 in cancer patients
Read More
tfAAC94 safe in patients with inflammatory arthritis
Read More
Study identifies optimal alfimeprase dose for peripheral arterial occlusion
Read More
Apadenoson a potential agent for myocardial perfusion imaging
Read More
Activity of belimumab evaluated at 76 weeks in SLE patients
Read More
Studies detail potential of ruboxistaurin in diabetic cardiomyopathy
Read More
SBIR grant will support Alzheimer's diagnostic study of LymPro Test
Read More
Synairgen licenses novel peptide for treatment of asthma
Read More
GSK and NeuroSearch expand scope of strategic alliance
Read More
Improved antitumor efficacy of PEGylated SN38 derivative over SN38 and irinotecan
Read More
Intravail technology provides effective oral delivery of antisense drugs in primates
Read More
Phase III findings for Aridol to form Q2 2007 NDA filing
Read More
Bioheart expands clinical trials of MyoCell adult myogenic stem cell treatment
Read More
New phase II trial evaluates PXD-101 in MDS
Read More
Introgen licenses new nanotechnology systems
Read More
CollaGenex raises funds through sale of common stock
Read More
Enrollment completed in pivotal Tocosol Paclitaxel study
Read More
Johnson & Johnson to acquire Conor Medsystems
Read More
MN-001 begins phase III program in bronchial asthma
Read More
NorLevo begins phase I trial in Japan
Read More
European orphan drug designation for OAS-PAC-100 in ovarian cancer
Read More
Neupro recommended for approval in E.U. for advanced Parkinson's
Read More
Emerging companies showcased at BIO-Europe 2006: Palau Pharma
Read More
European CHMP recommends approval of Inovelon for Lennox-Gastaut syndrome
Read More
Lucentis recommended for approval in E.U. for wet AMD
Read More
Negative opinion handed down for Mycograb in E.U.
Read More
Exforge recommended for approval in E.U.
Read More
Recent Protemix and Dainippon Sumitomo patents describe new antidiabetic agents
Read More
New therapeutic agents for schizophrenia, anxiety, etc. disclosed in recent patents
Read More
New agents for treating neurological disorders reported in recent patents
Read More
